Concord, CA – Cerus Corporation has announced the appointment of Vivek Jayaraman as President and Chief Executive Officer. About Cerus Corporation: Cerus Corporation is an American biotechnology company headquartered in Concord, California, dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. The company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. Additionally, in the US, the INTERCEPT Blood System for Cryoprecipitation is approved for the production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, a therapeutic product for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, while the INTERCEPT red blood cell system is in late-stage clinical development.

For more information on Cerus Corporation please visit: https://www.cerus.com/

Cerus Corporation
1220 Concord Avenue
Concord, CA 94520
Phone: 925-288-6000
LinkedIn Page: https://www.linkedin.com/company/cerus/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved